Sign in

CIK 0001321834

  • Non-accelerated filer
  • Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-13 Glass Mitchell Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +50,000 50,000
2025-11-14 Glass Mitchell Director, Chief Medical Off. Grant or award +11,420 12,500
2025-10-03 Glass Mitchell Director, Chief Medical Off. Grant or award +1,080 1,080
2025-04-17 Glass Mitchell President, CMO Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000

Page 1 of 1 · 4 trades